Daniel Francis Hanley

NMT Medical, Inc. is an advanced medical technology company. It designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. The company was founded in July 1986 and is headquartered in Boston, MA

Encore Path, Inc. designs and develops treatment for stroke symptoms related to arm function. Its Tailwind, Encore Path's debut product, permanently improves arm movement in patients who have lost upper extremity function due to stroke or other brain injuries. The company was founded by Kristen Appel in 2006 and is headquartered in Baltimore, MD.

Johns Hopkins Medicine, Inc. owns and operates hospitals. It offers health care services in the areas of burn and wound care, cardiac surgery, cardiology, endocrinology, gastroenterology, gynecology/obstetrics, innovation in quality patient care, internal medicine, nephrology, neurology, neurosurgery, oncology, orthopedic surgery, otolaryngology-head and neck surgery. The company was founded by Johns Hopkins in 1997 and is headquartered in Baltimore, MD.

International Olympic Committee Organizes Olympic games. The company was founded by Pierre de Coubertin on June 23 1894 and is headquartered in Lausanne, Switzerland.

EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020.